ABLYNX (D)
Identification
Ticker
ABLX
Codice ISIN
BE 0003877942
Mercato
Euronext
Borsa
Brussels
Products family
Stocks
Market organization
EuronextBrussels
ICB
Biotechnology
Activity description
Ablynx specializes in the research and development of nanobodies (therapeutic proteins made from natural antibody fragments) intended to improve treatments for inflammatory diseases, thrombosis, cancer, and Alzheimer's disease. Net sales break down by type of income as follows:
- revenues from partnership agreements (94.6%);
- subsidies (5.4%).
Indirizzo web
www.ablynx.com
Indirizzo web
www.ablynx.com
Operation
Data IPO
Mar 09/03/2010
Tipologia IPO
New Issue Special Session
Categoria
New Issue Special Session
Procedura
OFFER SHARES